Treosulfan, thiotepa and fludarabine conditioning regimen prior to first allogeneic stem cell transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromes: a single center experience

被引：2
|
作者：
Cassanello, G. [1 ]
Serpenti, F. [1 ]
Bagnoli, F. [2 ]
Saporiti, G. [3 ]
Goldaniga, M. [3 ]
Cavallaro, F. [3 ]
Barbullushi, K. [1 ]
Bellani, V. [1 ]
Galassi, G. [3 ]
Onida, F. [1 ,3 ]
机构：
[1] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy
[2] IRCCS Humanitas Res Hosp, Human Canc Ctr, Milan, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 09期
关键词：
INDEX;
D O I：
10.1038/s41409-023-02023-2
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1059 / 1061
页数：3
相关论文
共 50 条
  • [41] Allogeneic hematopoietic stem cell transplantation after Treosulfan/Fludarabine conditioning in high-risk patients with hematologic malignancies. Dose escalation of Treosulfan.
    Jochen, C
    Blau, W
    Volin, L
    Ruutu, T
    Wandt, H
    Schaefer-Eckart, K
    Holowiecki, J
    Giebel, S
    Aschan, J
    Zander, AR
    Kroeger, N
    Freund, M
    Knauf, WU
    BLOOD, 2003, 102 (11) : 467A - 467A
  • [42] Busulfan and Fludarabine As Conditioning Regimen for Unrelated Allogeneic Stem Cell Transplant: A Single-Center Experience
    Sutamtewagul, Grerk
    Abbi, Kamal Kant Singh
    Farooq, Umar
    Mott, Sarah L.
    Dozeman, Lindsay
    Silverman, Margarida
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S358 - S358
  • [43] Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome
    Schmid, C
    Schleuning, M
    Ledderose, G
    Tischer, J
    Kolb, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5675 - 5687
  • [44] Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma
    Schmidt-Hieber, M.
    Blau, I. W.
    Trenschel, R.
    Andreesen, R.
    Stuhler, G.
    Einsele, H.
    Kanz, L.
    Keilholz, U.
    Marinets, O.
    Beelen, D. W.
    Fauser, A. A.
    Volin, L.
    Ruutu, T.
    Uharek, L.
    Fietz, T.
    Knauf, W.
    Hopfenmueller, W.
    Thiel, E.
    Freund, M.
    Casper, J.
    BONE MARROW TRANSPLANTATION, 2007, 39 (07) : 389 - 396
  • [45] Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma
    M Schmidt-Hieber
    I W Blau
    R Trenschel
    R Andreesen
    G Stuhler
    H Einsele
    L Kanz
    U Keilholz
    O Marinets
    D W Beelen
    A A Fauser
    L Volin
    T Ruutu
    L Uharek
    T Fietz
    W Knauf
    W Hopfenmüller
    E Thiel
    M Freund
    J Casper
    Bone Marrow Transplantation, 2007, 39 : 389 - 396
  • [46] COMPARISON OF FLUDARABINE-MELPHALAN AND FLUDARABINE-TREOSULFAN AS CONDITIONING REGIMENS PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Liga, Maria
    Tsokanas, Dimitris
    Sagiadinou, Eleftheria
    Lysandrou, Memnon
    Georgopoulou, Angeliki
    Triantafyllou, Evangelia
    Zacharioudaki, Vassiliki
    Christopoulou, Anastasia
    Spyridonidis, Alexandros
    BONE MARROW TRANSPLANTATION, 2024, 59 : 273 - 274
  • [47] Toxicity-reduced conditioning with treosulfan and fludarabine prior to allogeneic blood stem cell transplantation.
    Casper, J
    Wilhelm, S
    Steiner, B
    Wolff, D
    Hammer, U
    Wegener, R
    Kleine, HD
    Freund, M
    BLOOD, 2000, 96 (11) : 298B - 298B
  • [48] Fludarabine and melphalan conditioning regimen in young patients with acute myeloid leukemia in CR1 undergoing a matched related allogeneic stem cell transplant: A single center experience
    Chandy, Mammen
    Mathews, Vikram
    Rajasekar, T.
    Lakshmi, Kavitha M.
    Viswabandya, Auro
    John, Joseph M.
    George, Biju
    Srivastava, Alok
    BLOOD, 2007, 110 (11) : 342B - 342B
  • [49] Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation
    Anne Banet
    Ali Bazarbachi
    Myriam Labopin
    Nicolas Stocker
    Rémy Duléry
    Florent Malard
    Zoé Van de Wyngaert
    Alexis Genthon
    Mara Memoli
    Ollivier Legrand
    Agnes Bonnin
    Tounes Ledraa
    Ramdane Belhocine
    Simona Sestili
    Jean El-Cheikh
    Mohamad Mohty
    Eolia Brissot
    Bone Marrow Transplantation, 2023, 58 : 61 - 67
  • [50] Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia
    Krejci, Marta
    Doubek, Michael
    Dusek, Jaroslav
    Brychtova, Yvona
    Racil, Zdenek
    Navratil, Milan
    Tomiska, Miroslav
    Horky, Ondrej
    Pospisilova, Sarka
    Mayer, Jiri
    ANNALS OF HEMATOLOGY, 2013, 92 (10) : 1397 - 1403
12345